DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8
Proceedings of the National Academy of Sciences · 13.02.2024 · 121 (7)
DOI: 10.1073/pnas.2310264121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.02.2024. Verfasst von Gaurav Swarnkar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110. Hauptthemen laut MEDLINE: Azacitidine, Arthritis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Epigenetic regulation plays a crucial role in the pathogenesis of autoimmune diseases such as inflammatory arthritis. DNA hypomethylating agents, such as decitabine (DAC), have been shown to dampen inflammation and restore immune homeostasis. In the present study, we demonstrate that DAC elicits potent anti-inflammatory effects and attenuates disease symptoms in several animal models of arthritis. Transcriptomic and epigenomic profiling show that DAC-mediated hypomethylation regulates a wide range of cell types in arthritis, altering the differentiation trajectories of anti-inflammatory macrophage populations, regulatory T cells, and tissue-protective synovial fibroblasts (SFs). Mechanistically, DAC-mediated demethylation of intragenic 5'-Cytosine phosphate Guanine-3' (CpG) islands of the transcription factor Irf8 (interferon regulatory factor 8) induced its re-expression and promoted its repressor activity. As a result, DAC restored joint homeostasis by resetting the transcriptomic signature of negative regulators of inflammation in synovial macrophages (MerTK, Trem2, and Cx3cr1), T REGs (Foxp3), and SFs (Pdpn and Fapα). In conclusion, we found that Irf8 is necessary for the inhibitory effect of DAC in murine arthritis and that direct expression of Irf8 is sufficient to significantly mitigate arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO 63110.
- HealthSpan Technologies, Inc, St. Louis, MO 63110.
- Department of Orthopedics and Physical Performance, University of Rochester, Rochester, NY 14642.
- Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110.
ORCID-Profile: Gaurav Swarnkar, Nicholas P Semenkovich, Syeda Kanwal Naqvi, Gabriel Mbalaviele, Chia-Lung Wu, Yousef Abu-Amer
Förderung
- NIAMS NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- HHS | National Institutes of Health
- Shriners Hospitals for Children
Zitieren
APA
Swarnkar, G., Semenkovich, N. P., Arra, M., Mims, D. K., Naqvi, S. K., Peterson, T., Mbalaviele, G., Wu, C. L., & Abu-Amer, Y. (2024). DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8. Proceedings of the National Academy of Sciences, 121(7). https://doi.org/10.1073/pnas.2310264121
Vancouver
Swarnkar G, Semenkovich NP, Arra M, Mims DK, Naqvi SK, Peterson T, et al. DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8. Proceedings of the National Academy of Sciences. 2024;121(7). doi:10.1073/pnas.2310264121
BibTeX
@article{Swarnkar2024,
author = {Swarnkar, Gaurav and Semenkovich, Nicholas P and Arra, Manoj and Mims, Dorothy K and Naqvi, Syeda Kanwal and Peterson, Timothy and Mbalaviele, Gabriel and Wu, Chia-Lung and Abu-Amer, Yousef},
title = {DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {7},
doi = {10.1073/pnas.2310264121}
}
EUVIMED